Dark

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR

At Close

Dec 5, 2025 3:59:30 PM EST

12.04USD-36.330%(-6.87)540,509

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 5, 2025 9:28:30 AM EST

13.00USD-31.253%(-5.91)38,334

After-hours

Dec 5, 2025 4:45:30 PM EST

11.50USD-4.485%(-0.54)594

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

10.13M

Headquarters

23 Hataas St, Kfar Sava, Israel

Industry

Biotechnology

Last Split

Apr 9, 20251for35reverse

QNRX Stats

Avg. Vol. 10 Day

103,372

Avg. Vol. 30 Day

711,177

Market Cap

10,134,842

Shares Out.

838,977

On/Off Exchange

59%/41%

6 Month Beta

-6.69

1 Year Beta

-1.22

2 Year Beta

-0.93

3 Year Beta

-0.57

52 Week Low

5.01

52 Week High

41.80

SMA50

13.40

SMA200

9.54

1 Week

-44.46%

1 Month

+40.96%

3 Month

+59.79%

6 Month

+36.96%

1 Year

-56.86%

2 Year

-93.03%

5 Year

-100.00%

Profile

cellect biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. achieving higher selectivity, greater specificity and decreased toxicity, cellect envisions its products becoming an integral and essential part of bone marrow transplantation (bmt), as well as integrated into many aspects of regenerative medicine.

QNRX Stock Summary

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) stock price today is $12.04, and today's volume is 540,509. QNRX is down -36.330% today. The 30 day average volume is 711,177. QNRX market cap is 10.13M with 838,977 shares outstanding.

.dark-mode .h5Zczs{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .h5Zczs{ color: #333333; background-color: white; border: 2px solid #333333; }QNRXQuoin Pharmaceuticals, Ltd.stock NASDAQ ADR

QNRX Stock Summary

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR